Choice of Systemic Drugs for the Management of Moderate-to-severe Psoriasis: A Cross-country Comparison Based on National Health Insurance Data.

This study highlights discrepancies between France and the Netherlands concerning the choice of first non-biologic agent and first biologic agent for patients with psoriasis. These discrepancies may be due to differences in the healthcare systems between the 2 countries.
PMID: 33585948 [PubMed - as supplied by publisher]

Source: Acta Dermato-Venereologica - February 15, 2021 Category: Dermatology Authors: Sbidian E, Mezzarobba M, Shourick J, Billionnet C, Coste J, Weill A, Rudant J, Chosidow O, Hollestein L, Nijsten T Tags: Acta Derm Venereol Source Type: research